| Type 2 Diabetes Mellitus |
1 |
0.92 |
| Adolescent Medicine |
0 |
0.76 |
| Child |
0 |
0.56 |
| Type 1 Diabetes Mellitus |
0 |
0.42 |
| Obesity |
0 |
0.35 |
| Polyuria |
0 |
0.26 |
| Metabolism |
0 |
0.2 |
| Metabolic Syndrome |
0 |
0.12 |
| Acanthosis Nigricans |
0 |
0.1 |
| Diabetic Ketoacidosis |
0 |
0.1 |
| Dyslipidemia |
0 |
0.1 |
| Fatigue |
0 |
0.1 |
| Weight Loss |
0 |
0.1 |
| Lipids Management |
0 |
0.09 |
| Polycystic Ovary Syndrome |
0 |
0.07 |
| Hypertension |
0 |
0.06 |
| Weight Management |
0 |
0.06 |
| Antigens |
0 |
0.05 |
| Body Mass Index |
0 |
0.05 |
| Candida |
0 |
0.05 |
| Care Management |
0 |
0.05 |
| Epidemiology |
0 |
0.05 |
| Hospital |
0 |
0.05 |
| Hyperglycemia |
0 |
0.05 |
| Insulin Resistance |
0 |
0.05 |
| Insulinoma |
0 |
0.05 |
| Ovary |
0 |
0.05 |
| Patient History |
0 |
0.05 |
| Preventive Screening |
0 |
0.05 |
| Puberty |
0 |
0.05 |
| Revenue and Practice Management |
0 |
0.05 |
| Salary and Compensation |
0 |
0.05 |
| Vulvovaginitis |
0 |
0.05 |
| Biologic Therapy |
0 |
0.03 |
| Fungal Infection |
0 |
0.03 |
| Infertility Female |
0 |
0.03 |
| Neuroendocrine Tumor |
0 |
0.03 |
| Skin and Soft Tissue Infection |
0 |
0.03 |
| Vaginitis |
0 |
0.03 |